Failure of PDE5 inhibitor use: A case of nonresponder?

Journal of Sexual Medicine

Volumn 7, Issue 4 PART 1, 2010, Pages 1321-1323

  Chung, Eric ^a  

^a St Joseph Health Care   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL; VASOACTIVE AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CIGARETTE SMOKING; DIABETES MELLITUS; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MALE; MALE GENITAL SYSTEM SURGERY; OBESITY; PATIENT REFERRAL; PENIS PROSTHESIS; PRESCRIPTION; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT FAILURE; VACUUM;

EID: 77955242666     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01772.x     Document Type: Article

References (11)

1. Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, Christ G, Hatzichristou D, Hirsch M, Kimoto Y, Lewis R, McKenna K, MacMahon C, Morales A, Mulcahy J, Padma-Nathan H, Pryor J, de Tejada IS, Shabsigh R, Wagner G. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2004, 1:6-23.
2. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998, 338:1397-404.
3. Lue TF. Erectile dysfunction. N Engl J Med 2000, 342:1802-13.
4. Carson CC, Lue TF. Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int 2005, 96:256-80.
5. Carson CC, Giuliano F, Goldstein I, Hatzichristou D, Hellstrom W, Lue T, Montorsi F, Munariz R, Nehra A, Porst H, Rosen R. The "effectiveness" scale-therapeutic outcome of pharmacologic therapies for ED: An international consensus panel report. Int J Impot Res 2004, 16:207-13.
6. McCullough AR, Brada JH, Fawzy A, Guay AT, Hatzichristou D. Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction. Urology 2002, 60:28-38.
7. Gruenwald I, Shenfeld O, Chen J, Raviv G, Richter S, Cohen A, Vardi Y. Positive effect of counselling and dose adjustment in patients with erectile dysfunction who failed treatment with sildenafil. Eur Urol 2006, 50:134-40.
8. Berner MM, Kriston L, Harms A. Efficacy of PDE-5-inbitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations. Int J Impot Res 2006, 18:229-35.
9. McMahon C. Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil. J Sex Med 2004, 1:292-300.
10. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2008, 179:S97-102. 5 Suppl
11. Canguven O, Bailen J, Fredriksson W, Bock D, Burnett AL. Combination of vacuum erection device and PDE5 inhibitors as salavage therapy in PDE5 inhibitor nonresponders with erectile dysfunction. J Sex Med 2009, 6:2561-7.